The recommendation would leave the choice of PCV up to the clinician. The updated language calls for a single dose of PCV ...

Oral semaglutide improved liver health, diabetes status, and lipid profile in patients with MASLD and T2D, with weight loss ...

With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate ...

About 1 in 3 medical residents in a Medscape survey said they find time to tend to their own health "never" or "rarely." ...

Gender-affirming care happens not only with medications but with communication, curiosity, and respect,” Boos said.

FM providers backed up by general surgeons can deliver a high standard of obstetric care, suggesting that this team-based ...

A study found significant disparities in mortality due to cardiac arrest and patient disposition across age groups, races, ...

A greater proportion of women in the intervention group reported tolerable pain during placement and expressed a willingness ...

The use of a levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with an increased risk for breast cancer.

The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...

An analysis of over 400,000 patients with T1D revealed a rise in prescribing for glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors over the past decade.

Adding a second checkpoint inhibitor to chemotherapy improves outcomes among patients with non–small cell lung cancer (NSCLC) who have STK11 and/or KEAP1 mutations, according to the authors of a new ...